EHI
AXNX

Eagle Health Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Eagle Health Investments’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-110,560
Closed -$7.79M – 30
2022
Q3 		$7.79M Sell
110,560
-145,905
-57% -$10.1M 1.79% 20
2022
Q2 		$14.5M Hold
256,465
– – 3.39% 15
2022
Q1 		$16.1M Hold
256,465
– – 3.96% 13
2021
Q4 		$14.4M Buy
256,465
+66,100
+35% +$4.04M 3.5% 14
2021
Q3 		$12.4M Sell
190,365
-44,200
-19% -$3.02M 3.93% 13
2021
Q2 		$14.9M Buy
234,565
+39,600
+20% +$2.34M 5.1% 8
2021
Q1 		$11.7M Buy
194,965
+12,125
+7% +$659K 4.58% 11
2020
Q4 		$9.13M Buy
+182,840
New +$8.58M 5.84% 8

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Eagle Health Investments's AXNX Position: Q4 2022 in Review

Eagle Health Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 110,560 shares — an estimated $7.79M sold.

Eagle Health Investments first reported a position in AXNX in Q4 2020 and held it in 8 quarters. The position peaked at $16.1M in Q1 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

  • Eagle Health Investments reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Eagle Health Investments sold 110,560 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $7.79M.
  • Eagle Health Investments first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Eagle Health Investments's Axonics, Inc. Common Stock position peaked at $16.1M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on Eagle Health Investments's 13F filing for Q4 2022, filed 13 Feb 2023.